US3886940A - Capsule - Google Patents

Capsule Download PDF

Info

Publication number
US3886940A
US3886940A US151032A US15103271A US3886940A US 3886940 A US3886940 A US 3886940A US 151032 A US151032 A US 151032A US 15103271 A US15103271 A US 15103271A US 3886940 A US3886940 A US 3886940A
Authority
US
United States
Prior art keywords
capsule
side wall
externally
open
tubular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US151032A
Inventor
Gerd Hunger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19702034336 external-priority patent/DE2034336C3/en
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of US3886940A publication Critical patent/US3886940A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules

Definitions

  • This comprises a two piece capsule, which when assembled with the medicament therein, may be generally characterized as thimble shaped.
  • the open end provides a receptacle in which the tip of a finger may be inserted so that the capsule may be easily and accurately introduced to the right place.
  • the capsule Upon withdrawal of the finger, the capsule remains where placed and the rim resists the natural tendency for the capsule to be expelled.
  • FIG. 1 shows a cross section of the two piece capsule wherein the second half is inserted into the first half with the external wall also within the first half.
  • FIG. 2 shows a cross section of the two piece capsule wherein the rim of the external wall of the second half abuts the rim of the first half.
  • FIG. 3 shows a modification of the capsule shown in FIG. 1 in which the external walls extend beyond the closed end of the second half.
  • FIG. 4 shows a modification of the capsule shown FIG. 2 in which the second half has smaller proportions.
  • the capsule of this invention particularly adapted for intravaginal use comprises two parts which, for the sake of convenience of reference, are termed here the top cap portion and the bottom closure portion. These are designated in the Figures as 1 and 2, respectively.
  • Both parts are tubular in shape, hollow and open ended somewhat similarly to the conventional two piece dry-fill gelatin capsule for oral administration.
  • the bottom, closure portion differs, however, in that it is twin walled over some or all of its length. That is, the wall of this part is folded over or reversed on itself externally so as to form an annular, outside side wall about one-fourth to three-fourths of the length of this closure portion as in FIGS. 1, 2 and 4 or even longer as in FIG. 3.
  • the external side wall is a continuation of the internal side wall of the capsule through a U-shaped bend which provides a smoothly curved rim 8 rather than a sharp edge.
  • the interior side wall is designated 3 and the annular external side wall is designated 4 in each of the Figures.
  • the closed end 5 of the second part of the capsule is in- "serted into the open end of the first, cap portion 1 thus leaving the open end of the second half as an aperture
  • the bottom portion 2 is telescopically inserted into the cap portion 1, so that the external side wall 4 extends partially within the cap forming a tight, friction-fit closure.
  • the external side wall 4 extends only part way along the inside wall of the capsule as indicated in that figure.
  • the internal side wall of the bottom part is telescopically inserted into the cap and forms the tight closure by friction fit.
  • the external side wall does not extend into the cap and its rim 6 abuts the rim of the cap.
  • the external side wall 4 extends beyond the closed end 5 shortening the aperture 9 in this instance to about one-fourth to one-half the length of the external wall.
  • a shortened aperture 9 is also shown in the modification of FIG. 4.
  • the diameter of the bottom, portion 2 is suitably adjusted in size in the respective modifications so that a tight closure, sealing and protecting the contents, is made.
  • the medicament to be carried by the capsule, and any vehicle or excipient conventionally formulated with such medicament is contained within the space formed between the closed ends of the two parts of the capsule, i.e., the chamber 7.
  • the medicament carried by the capsule may be liquid, semi-solid or solid as in the conventional capsule for oral administration.
  • Any agent intended for intravaginal use may be administered in this form, e.g., trichomonacides and other antimicrobial agents, antiinflammatory agents, etc.
  • the capsule may be produced from conventional materials, i.e., hard or soft gelatin or other substances used for oral capsules, which melt or disintegrate at internal body temperature or in the presence of moisture or other secretions.
  • the wall of the bottom, closure portion of the capsule is fabricated longer than the conventional capsule half so that a portion of this wall may be folded over itself to form the external wall of appropriate length.
  • the external wall is a continuation of the internal wall and turned in such a fashion that the rim 8 forms a smooth curve. The smooth curve avoids a sharp edge which may injure the finger which is used to insert the capsule or, more importantly, the delicate internal tissues.
  • the capsules for intravaginal use are larger in overall size than capsules for oral administration i.e., somewhat larger than the 000 oral size and more of the order of veterinary II or 12 capsules.
  • the active medicament either singly or a mixture, and any additional materials such as a solvent, vehicle, excipient or the like, normally formulated with it, is placed in the cap in appropriate dosage and proportions. Then the bottom part is inserted into the cap, closed end forward so that the therapeutic material is enclosed within the chamber formed between the two halves of the capsule.
  • the capsules are so formed that the external wall in the modifications of FIGS. 1 and 3 or the internal wall in the modifications of FIGS. 2 and 4 provide a tight closure by friction fit encasing and protecting the material within the capsule. When the two parts are fit together, the overall contours are suggestive of a thimble with a thickened end.
  • the open end of the bottom half of the capsule provides an aperture 9 into which the tip of a finger may be inserted in order to introduce the capsule into the vagina.
  • the two modifications shown particularly permit medicaments to be introduced deep into the vagina without difficulty.
  • the capsule has the additional advantage over vaginal tablets and vaginal ovules frequently used in that the difficulties of disintegration in a dry inflammation of the vagina are overcome. Whereas vaginal tablets and ovules remain as solid bodies in the case of insufficient secretion, cause pressure pains and especially do not release the medicament, a gelatin capsule is softened by minimal fluid content and the power or fluid content of a capsule adjust to local conditions without producing undesirable pressure.
  • a two piece capsule comprising a first tubular half open at one end and a second tubular half open at one end, the side wall of said second half being folded over externally on itself at the open end, the second half fitting telescopically, closed end forward, into said first half and forming a chamber between the closed ends of said halves.

Abstract

A two piece capsule comprising a first, tubular open ended half and a second tubular open ended half in which the side wall is folded over externally on itself to form an annular outer wall, the closed end of the second half being inserted into the open end of the first half, is particularly suitable for intravaginal use.

Description

United States Patent 11 1 [111 3,886,940
Hunger 1 June 3, 1975 [54] CAPSULE 2,020,107 11/1935 Cruickshank 128/271 9 [75] Inventor: Gerd Hunger, Munich, Germany 73 Assigmae; Squibb & sons, Inc 3.342.181 9/1967 Jacquignon 128/271 Princeton, NJ. FOREIGN PATENTS OR APPLICATIONS [22] Filed: June 8, 1971 479 1/1888 United Kingdom 128/271 776,975 2 1935 F 128 271 211 Appl. No.: 151,032 I I Primary ExaminerRichard A. Gaudet [30] Foreign Application Priority Data Attorney, Agent, or Firm-Lawrence S. Levinson;
July 10, 1970 Germany 2034336 Merle Smth July 10, 1970 Germany 7026065 [57] ABSTRACT [52] US. Cl. 128/271 A two piece capsule comprising a first, tubular open [51] Int. Cl A6lm 31/00 ended half and a second tubular open ended half in [58] Field of Search 128/260, 270, 271, 128 which the side wall is folded over externally on itself to form an annular outer wall, the closed end of the [56] References Cited second half being inserted into the open end of the UNITED STATES PATENTS first half, is particularly suitable for intravaginal use.
1,707,762 4/1929 Homan 128/271 7 Claims, 4 Drawing Figures FIG. I
FIGZ
CAPSULE BACKGROUND AND SUMMARY; OF THE INVENTION When medic'aments are applied intravaginally, the
therapeutic result depends upon inserting the medicament as deeply as possible into the vagina. Introduction with a finger of conventional therapeutic forms for the intravaginal application of medicines, namely vaginal tablets, vaginal ovules or even vaginal suppositories, often leads to difficulties, since the finger can slip past them and the medicament is not pushed forward to the desired place of application. There are also applicators which may be used repeatedly over a period of time.
Experience has shown, however, that these applicators are often not sufficiently cleaned by thepatient and above all not disinfected or sterilized so that in the case of infections of the vagina the danger of reinfection remains. I
It has now been found that these difficulities may be overcome by means of a new form for these medicaments. This comprises a two piece capsule, which when assembled with the medicament therein, may be generally characterized as thimble shaped. The open end provides a receptacle in which the tip of a finger may be inserted so that the capsule may be easily and accurately introduced to the right place. Upon withdrawal of the finger, the capsule remains where placed and the rim resists the natural tendency for the capsule to be expelled.
THE DRAWING FIG. 1 shows a cross section of the two piece capsule wherein the second half is inserted into the first half with the external wall also within the first half.
FIG. 2 shows a cross section of the two piece capsule wherein the rim of the external wall of the second half abuts the rim of the first half.
FIG. 3 shows a modification of the capsule shown in FIG. 1 in which the external walls extend beyond the closed end of the second half.
FIG. 4 shows a modification of the capsule shown FIG. 2 in which the second half has smaller proportions.
DETAILED DESCRIPTION OF THE INVENTION The capsule of this invention, particularly adapted for intravaginal use comprises two parts which, for the sake of convenience of reference, are termed here the top cap portion and the bottom closure portion. These are designated in the Figures as 1 and 2, respectively.
Both parts are tubular in shape, hollow and open ended somewhat similarly to the conventional two piece dry-fill gelatin capsule for oral administration. The bottom, closure portion differs, however, in that it is twin walled over some or all of its length. That is, the wall of this part is folded over or reversed on itself externally so as to form an annular, outside side wall about one-fourth to three-fourths of the length of this closure portion as in FIGS. 1, 2 and 4 or even longer as in FIG. 3. The external side wall is a continuation of the internal side wall of the capsule through a U-shaped bend which provides a smoothly curved rim 8 rather than a sharp edge.
The interior side wall is designated 3 and the annular external side wall is designated 4 in each of the Figures.
2 i As a second departure from the conventional, the closed end 5 of the second part of the capsule is in- "serted into the open end of the first, cap portion 1 thus leaving the open end of the second half as an aperture In the embodiment shown in FIG. 1, the bottom portion 2 is telescopically inserted into the cap portion 1, so that the external side wall 4 extends partially within the cap forming a tight, friction-fit closure.
In the embodiment shown in FIG. 2, the external side wall 4 extends only part way along the inside wall of the capsule as indicated in that figure. In this case, the internal side wall of the bottom part is telescopically inserted into the cap and forms the tight closure by friction fit. The external side wall does not extend into the cap and its rim 6 abuts the rim of the cap.
In another embodiment shown in FIG. 3, the external side wall 4 extends beyond the closed end 5 shortening the aperture 9 in this instance to about one-fourth to one-half the length of the external wall. A shortened aperture 9 is also shown in the modification of FIG. 4.
The diameter of the bottom, portion 2 is suitably adjusted in size in the respective modifications so that a tight closure, sealing and protecting the contents, is made.
The medicament to be carried by the capsule, and any vehicle or excipient conventionally formulated with such medicament is contained within the space formed between the closed ends of the two parts of the capsule, i.e., the chamber 7.
The medicament carried by the capsule may be liquid, semi-solid or solid as in the conventional capsule for oral administration. Any agent intended for intravaginal use may be administered in this form, e.g., trichomonacides and other antimicrobial agents, antiinflammatory agents, etc.
The capsule may be produced from conventional materials, i.e., hard or soft gelatin or other substances used for oral capsules, which melt or disintegrate at internal body temperature or in the presence of moisture or other secretions. The wall of the bottom, closure portion of the capsule is fabricated longer than the conventional capsule half so that a portion of this wall may be folded over itself to form the external wall of appropriate length. The external wall is a continuation of the internal wall and turned in such a fashion that the rim 8 forms a smooth curve. The smooth curve avoids a sharp edge which may injure the finger which is used to insert the capsule or, more importantly, the delicate internal tissues.
The capsules for intravaginal use are larger in overall size than capsules for oral administration i.e., somewhat larger than the 000 oral size and more of the order of veterinary II or 12 capsules.
The active medicament, either singly or a mixture, and any additional materials such as a solvent, vehicle, excipient or the like, normally formulated with it, is placed in the cap in appropriate dosage and proportions. Then the bottom part is inserted into the cap, closed end forward so that the therapeutic material is enclosed within the chamber formed between the two halves of the capsule. The capsules are so formed that the external wall in the modifications of FIGS. 1 and 3 or the internal wall in the modifications of FIGS. 2 and 4 provide a tight closure by friction fit encasing and protecting the material within the capsule. When the two parts are fit together, the overall contours are suggestive of a thimble with a thickened end. This is further suggested in that the open end of the bottom half of the capsule provides an aperture 9 into which the tip of a finger may be inserted in order to introduce the capsule into the vagina. The two modifications shown particularly permit medicaments to be introduced deep into the vagina without difficulty. The capsule has the additional advantage over vaginal tablets and vaginal ovules frequently used in that the difficulties of disintegration in a dry inflammation of the vagina are overcome. Whereas vaginal tablets and ovules remain as solid bodies in the case of insufficient secretion, cause pressure pains and especially do not release the medicament, a gelatin capsule is softened by minimal fluid content and the power or fluid content of a capsule adjust to local conditions without producing undesirable pressure.
What is claimed is:
1. A two piece capsule comprising a first tubular half open at one end and a second tubular half open at one end, the side wall of said second half being folded over externally on itself at the open end, the second half fitting telescopically, closed end forward, into said first half and forming a chamber between the closed ends of said halves.
2. A capsule as in claim 1 wherein the externally folded portion of the side wall extends about onefourth to three-fourths of the length of the second half of the capsule.
3. A capsule as in claim 1 wherein the externally folded portion of the side wall extends beyond said closed end.
4. A capsule as in claim 1 wherein a part of the externally folded portion of the side wall of the second half extends into the first half to form a tight closure.
.5. A capsule as in claim 1 wherein the rim of the externally folded portion of the side wall of the second half abuts the rim of the first half of the capsule in the closed position to form a tight closure.
6. A capsule as in claim 4 wherein a medicament is contained within the space formed between the two halves of the capsule.
7. A capsule as in claim 5 wherein a medicament is contained within the space formed between the two halves of the capsule.

Claims (7)

1. A two piece capsule comprising a first tubular half open at one end and a second tubular half open at one end, the side wall of said second half being folded over externally on itself at the open end, the second half fitting telescopically, closed end forward, into said first half and forming a chamber between the closed ends of said halves.
1. A two piece capsule comprising a first tubular half open at one end and a second tubular half open at one end, the side wall of said second half being folded over externally on itself at the open end, the second half fitting telescopically, closed end forward, into said first half and forming a chamber between the closed ends of said halves.
2. A capsule as in claim 1 wherein the externally folded portion of the side wall extends about one-fourth to three-fourths of the length of the second half of the capsule.
3. A capsule as in claim 1 wherein the externally folded portion of the side wall extends beyond said closed end.
4. A capsule as in claim 1 wherein a part of the externally folded portion of the side wall of the second half extends into the first half to form a tight closure.
5. A capsule as in claim 1 wherein the rim of the externally folded portion of the side wall of the second half abuts the rim of the first half of the capsule in the closed position to form a tight closure.
6. A capsule as in claim 4 wherein a medicament is contained within the space formed between the two halves of the capsule.
US151032A 1970-07-10 1971-06-08 Capsule Expired - Lifetime US3886940A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19702034336 DE2034336C3 (en) 1970-07-10 1970-07-10 Pharmaceutical form for intravaginal application
DE7026065 1970-07-10

Publications (1)

Publication Number Publication Date
US3886940A true US3886940A (en) 1975-06-03

Family

ID=25759420

Family Applications (1)

Application Number Title Priority Date Filing Date
US151032A Expired - Lifetime US3886940A (en) 1970-07-10 1971-06-08 Capsule

Country Status (2)

Country Link
US (1) US3886940A (en)
CA (1) CA951207A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027670A (en) * 1976-10-15 1977-06-07 Bronner Emanuel H Contraceptive device
US4347237A (en) * 1981-03-02 1982-08-31 Evenstad Kenneth L Lower fatty acid glyceride high-HLB lubricating suppository and method for making and using the same
US6080426A (en) * 1994-12-16 2000-06-27 Warner-Lamberg Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
US6245350B1 (en) 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
US20040072906A1 (en) * 2000-04-05 2004-04-15 Udell Ronald G. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
US20080161752A1 (en) * 2006-12-29 2008-07-03 Rajala Gregory J Delivery device
US20080268039A1 (en) * 2007-03-06 2008-10-30 Soft Gel Technologies, Inc. Loquat compositions
US9340004B2 (en) 2011-10-06 2016-05-17 Bio Capsule Pharmaceutical And Nutritional Products (Pty) Ltd. Method and apparatus for manufacturing a capsule
US9456987B2 (en) 2013-04-03 2016-10-04 Binutra, Inc. Capsule with internal diaphragm
CN106975145A (en) * 2015-04-18 2017-07-25 吴金玉 A kind of improved stype

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1707762A (en) * 1926-02-05 1929-04-02 John G Homan Medical capsule
US2020107A (en) * 1934-08-06 1935-11-05 George A Cruickshank Combination pessary and vaginal suppository
US2049270A (en) * 1932-11-15 1936-07-28 Ruth W Munro Medical device
US2105710A (en) * 1935-03-28 1938-01-18 Wadel Josef Casing for suppositories
US3342181A (en) * 1963-06-25 1967-09-19 Charles Albert Merminod Forms of ovules

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1707762A (en) * 1926-02-05 1929-04-02 John G Homan Medical capsule
US2049270A (en) * 1932-11-15 1936-07-28 Ruth W Munro Medical device
US2020107A (en) * 1934-08-06 1935-11-05 George A Cruickshank Combination pessary and vaginal suppository
US2105710A (en) * 1935-03-28 1938-01-18 Wadel Josef Casing for suppositories
US3342181A (en) * 1963-06-25 1967-09-19 Charles Albert Merminod Forms of ovules

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4027670A (en) * 1976-10-15 1977-06-07 Bronner Emanuel H Contraceptive device
US4347237A (en) * 1981-03-02 1982-08-31 Evenstad Kenneth L Lower fatty acid glyceride high-HLB lubricating suppository and method for making and using the same
US6080426A (en) * 1994-12-16 2000-06-27 Warner-Lamberg Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
US6245350B1 (en) 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
US7989005B2 (en) 2000-04-05 2011-08-02 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US20040072906A1 (en) * 2000-04-05 2004-04-15 Udell Ronald G. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US20080152705A1 (en) * 2000-04-05 2008-06-26 Soft Gel Technologies, Inc. Corosolic Acid Formulation and Its Application for Weight-Loss Management and Blood Sugar Balance
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
US20080161752A1 (en) * 2006-12-29 2008-07-03 Rajala Gregory J Delivery device
US7666160B2 (en) 2006-12-29 2010-02-23 Kimberly-Clark Worldwide, Inc. Delivery device
US20080268039A1 (en) * 2007-03-06 2008-10-30 Soft Gel Technologies, Inc. Loquat compositions
US9340004B2 (en) 2011-10-06 2016-05-17 Bio Capsule Pharmaceutical And Nutritional Products (Pty) Ltd. Method and apparatus for manufacturing a capsule
US10046549B2 (en) 2011-10-06 2018-08-14 Combocap, Inc. Method and apparatus for manufacturing a capsule
US20180264798A1 (en) * 2011-10-06 2018-09-20 Combocap, Inc. Method and apparatus for manufacturing a capsule
US9456987B2 (en) 2013-04-03 2016-10-04 Binutra, Inc. Capsule with internal diaphragm
CN106975145A (en) * 2015-04-18 2017-07-25 吴金玉 A kind of improved stype

Also Published As

Publication number Publication date
CA951207A (en) 1974-07-16

Similar Documents

Publication Publication Date Title
US3667465A (en) Applicator tubes for suppositories and the like
US3886940A (en) Capsule
US10940300B2 (en) Medicament applicator
US3424158A (en) Combination plastic mold,suppository package,dispenser and method for providing and using the same
US3086527A (en) Medical applicator
US2509241A (en) Applicator
WO2008081353A1 (en) Delivery device
US1575123A (en) Medical appliance
US10525242B2 (en) Method and apparatus for inserting a rectal suppository
US2110962A (en) Medical device
MX2007011818A (en) Dosage cap assembly for an applicator.
US8419712B2 (en) Method and apparatus for inserting a rectal suppository
US3828781A (en) Method for withdrawing menstrual fluid
US3664341A (en) Vaginal capsule
US2516846A (en) Applicator
US1222825A (en) Tampon or pessary.
US3642000A (en) Applicator
US2049270A (en) Medical device
CN206675810U (en) A kind of gynaecology's probiotic gel inducting device
CN107661566A (en) A kind of gynaecology's probiotic gel inducting device
US2705496A (en) Applicator
US3199512A (en) Valved dilating device for hygienic irrigation
WO2019018913A1 (en) Encasing device for dispensing topical products for oral, vulvar and anal use, which can be attached to a portable applicator for vaginal and rectal use
JPH0538748Y2 (en)
US20150005700A1 (en) Sanitary device for applying an active principle within a body cavity